
PBSA STATEMENT ON FDA DRAFT GUIDANCE ON NAMING OF BIOLOGICS
(August 27, 2015) Patients for Biologics Safety & Access (PBSA), a coalition of over 20 patient advocacy organizations dedicated to protecting patient access to safe and effective biologics, today released the following statement regarding the draft guidance on the naming of biosimilars and biologics put forward today by the Food ( more… )